Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...

Conclusions: Two-stage HRSN screening based on geography is suboptimal. Although a 2-stage approach based on area-level socioeconomic measures can reduce the number of patients requiring ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced the publication of findings from the randomized, phase III CALGB (Alliance)/SWOG 80702 study in JAMA Oncology.

While I don't think we're there yet, there may be parts of all of this that we can work with to our advantage. Maybe, getting ...

Treatment with omalizumab offers modest protection from allergic reactions to individuals with multiple food allergies, and ...

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

Most of Australia’s charity sector uses third-party data profiling services to label people, rank them, and even 'predict' ...

This year, psychological scientists tackled profound and varied questions to help us better understand ourselves and the ...

Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...